In yesterday’s Wall Street session, Heart Test Laboratories Inc (NASDAQ:HSCS) shares traded at $0.19, down -19.21% from the previous session.
1 analysts cover Heart Test Laboratories Inc (NASDAQ:HSCS), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.80 and a low of $3.80, we find $3.80. Given the previous closing price of $0.23, this indicates a potential upside of 1552.17 percent. HSCS stock price is now -59.43% away from the 50-day moving average and -80.52% away from the 200-day moving average. The market capitalization of the company currently stands at $1.97M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
The stock has received a hold rating from 0 analysts and a buy rating from 1. Brokers who have rated the stock have averaged $3.80 as their price target over the next twelve months.
A total of 30.17% of the company’s stock is owned by insiders.
On Thursday morning Heart Test Laboratories Inc (NASDAQ: HSCS) stock kicked off with the opening price of $0.2132. During the past 12 months, Heart Test Laboratories Inc has had a low of $0.14 and a high of $3.95. The fifty day moving average price for HSCS is $0.4560 and a two-hundred day moving average price translates $0.9497 for the stock.
The latest earnings results from Heart Test Laboratories Inc (NASDAQ: HSCS) was released for Jul, 2023. According to the Medical Devices Company, earnings per share came in at -$0.13, beating analysts’ expectations of -$0.14 by 0.01. This compares to -$0.28 EPS in the same period last year. The net profit margin was -315273.95% and return on equity was -519.34% for HSCS.
Heart Test Laboratories Inc(HSCS) Company Profile
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor’s offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
